29 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
8978857	17	Structure-activity relationships of phomactin derivatives as platelet activating factor antagonists.	Sankyo
7707324	22	Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.	Laboratorios Menarini
7658439	43	Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.	Pfizer
7658438	22	Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.	Pfizer
8027984	93	3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.	Abbott Laboratories
8478911	48	Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines.	Universit£
1578493	103	Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.	American Cyanamid
1433215	88	(Pyridylcyanomethyl)piperazines as orally active PAF antagonists.	J. Uriach & C£A.S.A.
1507200	40	1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.	Pfizer
2175357	11	4-Alkyl-1,4-dihydropyridines derivatives as specific PAF-acether antagonists.	Alter
2909744	27	Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.	Takeda Chemical Industries
3027330	7	Structure-activity relationships of kadsurenone analogues.	TBA
	7	Synthesis and biological activity of MK 287 (L-680,573): a potent, specific and orally active paf receptor antagonist	TBA
	34	Synthesis and evaluation of water soluble indole pyrrolothiazole paf antagonists	TBA
	30	Discovery and optimization of indole pyrrolothiazole paf antagonists	TBA
	37	The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists.	TBA
	33	Synthesis and bioactivities of heterocyclic lipids as PAF antagonists. 2	TBA
	51	Synthesis and bioactivities of heterocyclic lipids as PAF antagonists. 1	TBA
	13	Synthesis of bicyclic thiazolidine PAF antagonists	TBA
12570381	15	Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.	Columbia University
9651167	20	In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.	Seoul National University
9438024	94	Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.	Abbott Laboratories
8496938	38	Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.	American Cyanamid
8411016	76	Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.	J. Uriach & CíA.
7783144	10	Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of platelet activating factor.	Wellcome Research Laboratories
3020247	10	Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists.	TBA
1992139	89	Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.	J. Uriach & CíA.
1542094	20	4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists.	J. Uriach & CíA.
1317924	28	Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists.	Abbott Laboratories